dipyridamole has been researched along with Granulomas in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hauss, WH | 1 |
| Büchner, T | 1 |
| Wagner, H | 1 |
| Junge-Hülsing, G | 1 |
| Schmitt, G | 1 |
1 other study available for dipyridamole and Granulomas
| Article | Year |
|---|---|
[On the proliferation of granulation tissue cells. Autoradiographic studies with H3-thymidine on cotton-pellet granuloma in untreated and dipyridamole treated rats].
Topics: Animals; Autoradiography; Dipyridamole; Fibroblasts; Gossypium; Granulation Tissue; Granuloma; Histi | 1968 |